{
    "id": "correct_subsidiary_00047_1",
    "rank": 83,
    "data": {
        "url": "https://www.life-sciences-uk.com/product/luxiq-connetics-corporation-gsk-group-stiefel-laboratories-inc-2001-7686.html",
        "read_more_link": "",
        "language": "en",
        "title": "The UK Life Sciences Web Portal",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://www.life-sciences-uk.com/images/basics/lsuk-life-sciences-uk-portal-logo.svg",
            "https://www.life-sciences-uk.com/banner/ebd-group-20240621-650-100-bio-europe-2024-beu24-stockholm.jpg",
            "https://www.life-sciences-uk.com/images/content/products_n.gif",
            "https://www.life-sciences-uk.com/images/content/period_n.gif",
            "https://www.life-sciences-uk.com/images/content/organisation_n.gif",
            "https://www.life-sciences-uk.com/banner/ebd-group-20230818-650-200-world-of-partnering-opportunities.jpg",
            "https://www.life-sciences-uk.com/banner/consultech-20230614-650-300-secure-funding-rnd-grants-for-pharma-biotech.jpg",
            "https://www.life-sciences-uk.com/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg",
            "https://www.life-sciences-uk.com/banner/ebd-group-20240621-120-240-bio-europe-2024-beu24-stockholm.jpg",
            "https://www.life-sciences-uk.com/banner/consultech-20230614-120-180-secure-funding-rnd-grants-for-pharma-biotech_1.png",
            "https://www.life-sciences-uk.com/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg",
            "https://www.life-sciences-uk.com/banner/ebd-group-20230818-120-240-world-of-partnering-opportunities.jpg",
            "https://www.life-sciences-uk.com/banner/ebd-group-20240621-120-240-bio-europe-2024-beu24-stockholm.jpg",
            "https://www.life-sciences-uk.com/banner/kentro-design-20240415-120-180-design-is-key-to-your-success.jpg",
            "https://www.life-sciences-uk.com/banner/consultech-20230614-120-180-secure-funding-rnd-grants-for-pharma-biotech_1.png",
            "https://www.life-sciences-uk.com/banner/bionter-20230515-120-180-non-destructive-particle-testing.png",
            "https://www.life-sciences-uk.com/banner/ebd-group-20230818-120-240-world-of-partnering-opportunities.jpg",
            "https://www.life-sciences-uk.com/banner/ebd-group-20240621-120-240-bio-europe-2024-beu24-stockholm.jpg",
            "https://www.life-sciences-uk.com/banner/ebd-group-20230818-120-240-world-of-partnering-opportunities.jpg",
            "https://www.life-sciences-uk.com/banner/kentro-design-20240415-120-180-design-is-key-to-your-success.jpg",
            "https://www.life-sciences-uk.com/banner/consultech-20200313-120-180-e-col-gdpr-conform-home-office.jpg",
            "https://www.life-sciences-uk.com/banner/bionter-20230515-120-180-seeing-eve-the-particle-counter.png",
            "https://www.life-sciences-europe.com/images/basics/linkedin.svg",
            "https://www.life-sciences-europe.com/images/basics/twitter.svg",
            "https://www.life-sciences-uk.com/images/basics/lsus-life-sciences-usa-portal-logo.svg",
            "https://www.life-sciences-uk.com/images/basics/lse-life-sciences-europe-portal-logo.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "life sciences",
            "biotechnology",
            "United Kingdom",
            "UK",
            "Great Britain",
            "GB",
            "London",
            "Cambridge",
            "Oxford",
            "Edinburgh",
            "Manchester",
            "Glasgow",
            "Liverpool",
            "Wales",
            "England",
            "Scotland",
            "Ireland",
            "business intelligence",
            "economics",
            "mass spectrometry",
            "biochips",
            "microarrays",
            "proteomics",
            "genomics",
            "metabolomics",
            "molecular diagnostics",
            "bioinformatics",
            "laboratory equipment",
            "drug discovery",
            "laboratory \n                             automation",
            "business development",
            "market research",
            "property rights",
            "industrial organisation",
            "news",
            "deals",
            "products",
            "persons",
            "financings",
            "collaborations",
            "cancer",
            "infection"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Life Sciences Business Intelligence Web Portal for Great Britain and Ireland",
        "meta_lang": "",
        "meta_favicon": "https://www.life-sciences-uk.com/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "http://www.life-sciences-europe.com/product/luxiq-connetics-corporation-gsk-group-stiefel-laboratories-inc-2001-7686.html",
        "text": "Advertisement\n\nProduct › Details\n\nLuxiq®\n\nNext higher product group dermatic_oo Status 2005-01-01 sales existent Organisation Connetics Corporation Today Stiefel Laboratories Inc. Group GSK (Group)\n\nRecord changed: 2023-07-10\n\nAdvertisement\n\nMore documents for pharmaceutical\n\n[1] Oxford Biomedica plc. (7/17/24). \"Press Release: Oxford Biomedica Announces Chief Financial Officer Transition. Lucinda Crabtree to Join as Chief Financial Officer\". Basel....\n\n[2] Asceneuron S.A.. (7/16/24). \"Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases\". Lausanne & San Francisco, CA....\n\n[3] Scorpion Therapeutics, Inc.. (7/16/24). \"Press Release: Scorpion Therapeutics Announces $150 Million Series C Financing to Advance Leading Clinical-stage Precision Oncology Pipeline\". Boston, MA....\n\n[4] Myricx Pharma Ltd.. (7/8/24). \"Press Release: Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development\". London....\n\n[5] CureVac N.V.. (7/3/24). \"Press Release: GSK and CureVac to Restructure Collaboration into New Licensing Agreement\". London, Tübingen & Boston, MA....\n\n[6] CureVac N.V.. (7/3/24). \"Press Release: CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities\". Tübingen & Boston, MA....\n\n[7] Mission Therapeutics Ltd.. (7/2/24). \"Press Release: Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325\". Cambridge....\n\n[8] Cellular Origins Ltd.. (7/2/24). \"Press Release: Cellular Origins Acquires ACTIA Platform IP to Enhance Automated Cell Therapy Manufacturing\". Cambridge....\n\n[9] Valneva S.E.. (7/1/24). \"Press Release: Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, Ixchiq\". Saint Herblain....\n\n[10] NLC Ventures Netherlands B.V.. (6/24/24). \"Press Release: NLC Health Ventures Launches New Early-stage Drug Delivery Company\"....\n\nTo subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«\n\nFind more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]\n\nPlease visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)\n\nAdvertisement\n\n» top"
    }
}